- Cui L, Ma K, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in
Staphylococcus aureus. J Clin Microbiol 2003; 41:5–14. - Kolar M, Urbanek K, Vagnerova I, et al. The influence of antibiotic use on the occurrence of
vancomycin-resistant enterococci. J Clin Pharm Ther 2006; 31:67–72. - Cunha BA, Mickail N, Eisenstein L.E. faecalisvancomycin sensitive enterococci (VSE) bacteremia
unresponsive to vancomycin successfully treated with high dose daptomycin. Heart Lung 2007;
36:456–461. - Cunha BA. Vancomycin revisisted: a reapprasal of clinical use. Crit Care Clin 2008; 24:394–420.
- Edwards DJ, Pancorbo S. Routine monitoring of serum vancomycin concentrations: waiting for proof
of its value. Clin Pharm 1987; 6:652–654. - Freeman CD, Quintiliani R, Nightingale CH. Vancomycin therapeutic drug monitoring: is it
necessary. Ann Pharmacotherapy 1993; 27:594–598. - Rodvold KA, Zokufa H, Rotschafer JC. Routine monitoring of serum vancomycin concentrations: can
waiting be justified? Clin Pharm 1987; 6:655–658. - Karam CM, McKinnon PS, Neuhauser MM, et al. Outcome assessment of minimizing vancomycin
monitoring and dosing adjustments. Pharmacotherapy 1999; 19: 257–266. - Cunha BA, Mohan SS, Hamid N, et al. Cost ineffectiveness of serum vancomycin levels. Eu J Clin
Microbiol Infect 2007; 13:509–511. - Cunha BA, Ortega A. Antibiotic failure. Med Clin North Am 1995; 79:663–672.
- Watanakunakorn C. Antibiotic-tolerantStaphylococcus aureus. J Antimicrob Chemother 1978; 4:561–568.
- Cunha BA, Mikhail N, Eisenstein L. Persistent methicillin resistant bacteremiaS. aureus(MRSA) due
to linezolid “Tolerant Strain”. Heart Lung. 2008; 37:398–400. - Saribas S, Bagdatli Y. Vancomycin tolerance in enterococci. Chemotherapy 2004; 50:250–254.
- Cunha BA. Simplified clinical approach to community-acquired MRSA (CA-MRSA) infections. J Hosp
Infect 2008; 68:271–273. - Cunha BA. MSSA/MRSA acute bacterial endocarditis (ABE): clinical pathway for diagnosis &
treatment. Antibiotics Clin 2006; 10(S1):29–34. - Cunha BA. Clinical diagnostic and therapeutic pathway. Antibiotic Clin 2007; 11:413–414.
- Cunha BA. Clinical manifestations and antimicrobial therapy of methicillin resistantStaphylococcus
aureus(MRSA). Clin Microbiol Infect 2005; 11:33–42.
Intravenous Central Line Infections in Critical Care 217